WebMay 13, 2024 · Euglycemic diabetic ketoacidosis (EuDKA) secondary to Sodium-glucose co-transporter-2 inhibitors (SGLT2i) in type 2 diabetes mellitus (T2D) is a rare but … WebDec 28, 2024 · Aims: To investigate the main feature and the association between euglycemic diabetic ketoacidosis (euDKA) /diabetic ketoacidosis (DKA) and sodium …
SGLT2 Inhibitor-induced Euglycemic Diabetic Ketoacidosis
WebApr 13, 2024 · This paper provides an overview of euglycemic diabetic ketoacidosis (euDKA) associated with the use of sodium-glucose co-transporter 2 (SGLT2) inhibitors. euDKA is a rare but potentially life-threatening complication that can occur in patients taking SGLT2 inhibitors, and its clinical presentation differs from traditional diabetic … WebJun 23, 2024 · Therefore, the diagnosis of euglycemic diabetic ketoacidosis (eu-DKA) was made. She was successfully treated according to the DKA protocol and discharged in … line 6 wireless receiver rack
A Case of Euglycemic Diabetic Ketoacidosis Triggered by a Ketog…
WebJun 25, 2024 · Sodium–glucose cotransporter-2 (SGLT-2) inhibitors have been associated with euglycemic diabetic ketoacidosis. Precipitants to ketoacidosis include intercurrent illnesses, surgery, decreased carbohydrate intake, … WebApr 10, 2024 · Conclusions SGLT-2 inhibitors seem to be associated with euglycemic DKA and ketosis, perhaps as a consequence of their noninsulin-dependent glucose … WebJul 15, 2015 · Two recent cases advise against off-label use of SGLT2 inhibitors for T1DM patients and discuss possible mechanisms for the rare occurrence of euglycemic diabetic ketoacidosis. Recent reports have highlighted the relatively rare yet potentially serious risk of diabetic ketoacidosis (DKA) with SGLT2 inhibitor use. line 70 bus schedule